Lv11
90 积分 2026-04-04 加入
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2小时前
已完结
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
3个月前
已完结
Classification and definition of major flares in SLE clinical trials
3个月前
已完结
Derivation of the sledai. A disease activity index for lupus patients
3个月前
已完结
B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)
3个月前
已完结
Association between early immunophenotypic changes and therapeutic response of belimumab in patients with systemic lupus erythematosus
3个月前
已完结
Next stop in the treatment of refractory systemic lupus erythematosus: B-cell targeted combined therapy
3个月前
已完结
B cell-targeted therapies in systemic lupus erythematosus: Current status and perspectives
3个月前
已完结
皖公网安备34019202002308
